Chicago Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.48M | Buy |
27,111
+55
| +0.2% | +$6.44K | 0.08% | 110 |
|
|
2026
Q1 | $3.25M | Buy |
27,056
+6
| +0% | +$693 | 0.09% | 109 |
|
|
2025
Q4 | $2.85M | Buy |
27,050
+1,341
| +5% | +$126K | 0.07% | 120 |
|
|
2025
Q3 | $2.16M | Buy |
25,709
+423
| +2% | +$34.8K | 0.05% | 132 |
|
|
2025
Q2 | $2M | Sell |
25,286
-75
| -0.3% | -$5.96K | 0.05% | 134 |
|
|
2025
Q1 | $2.28M | Buy |
25,361
+53
| +0.2% | +$4.95K | 0.06% | 119 |
|
|
2024
Q4 | $2.52M | Buy |
25,308
+161
| +0.6% | +$16.6K | 0.07% | 113 |
|
|
2024
Q3 | $2.86M | Hold |
25,147
| – | – | 0.08% | 105 |
|
|
2024
Q2 | $3.11M | Buy |
25,147
+2,960
| +13% | +$381K | 0.09% | 99 |
|
|
2024
Q1 | $2.93M | Buy |
22,187
+665
| +3% | +$82K | 0.09% | 104 |
|
|
2023
Q4 | $2.35M | Sell |
21,522
-360
| -2% | -$37.4K | 0.08% | 107 |
|
|
2023
Q3 | $2.25M | Buy |
21,882
+275
| +1% | +$29.6K | 0.11% | 74 |
|
|
2023
Q2 | $2.49M | Buy |
21,607
+285
| +1% | +$32.4K | 0.11% | 74 |
|
|
2023
Q1 | $2.27M | Buy |
21,322
+15
| +0.1% | +$1.62K | 0.11% | 76 |
|
|
2022
Q4 | $2.36M | Buy |
21,307
+100
| +0.5% | +$10.2K | 0.13% | 78 |
|
|
2022
Q3 | $1.83M | Buy |
21,207
+70
| +0.3% | +$6.25K | 0.11% | 78 |
|
|
2022
Q2 | $1.93M | Hold |
21,137
| – | – | 0.11% | 81 |
|
|
2022
Q1 | $1.73M | Buy |
21,137
+300
| +1% | +$23.7K | 0.07% | 87 |
|
|
2021
Q4 | $1.6M | Buy |
20,837
+210
| +1% | +$16.7K | 0.06% | 94 |
|
|
2021
Q3 | $1.55M | Buy |
20,627
+1,951
| +10% | +$148K | 0.06% | 93 |
|
|
2021
Q2 | $1.45M | Sell |
18,676
-1,085
| -5% | -$80.7K | 0.06% | 92 |
|
|
2021
Q1 | $1.45M | Buy |
19,761
+850
| +4% | +$62.7K | 0.06% | 90 |
|
|
2020
Q4 | $1.48M | Hold |
18,911
| – | – | 0.07% | 90 |
|
|
2020
Q3 | $1.5M | Buy |
18,911
+120
| +0.6% | +$9.4K | 0.08% | 89 |
|
|
2020
Q2 | $1.39M | Hold |
18,791
| – | – | 0.08% | 90 |
|
|
2020
Q1 | $1.38M | Sell |
18,791
-304
| -2% | -$23.9K | 0.11% | 82 |
|
|
2019
Q4 | $1.66M | Buy |
19,095
+158
| +0.8% | +$13K | 0.1% | 90 |
|
|
2019
Q3 | $1.52M | Hold |
18,937
| – | – | 0.1% | 92 |
|
|
2019
Q2 | $1.51M | Hold |
18,937
| – | – | 0.1% | 92 |
|
|
2019
Q1 | $1.5M | Sell |
18,937
-463
| -2% | -$34.6K | 0.1% | 91 |
|
|
2018
Q4 | $1.41M | Hold |
19,400
| – | – | 0.12% | 84 |
|
|
2018
Q3 | $1.31M | Buy |
19,400
+980
| +5% | +$62.4K | 0.09% | 89 |
|
|
2018
Q2 | $1.07M | Buy |
18,420
+2,423
| +15% | +$137K | 0.09% | 100 |
|
|
2018
Q1 | $831K | Buy |
+15,997
| New | +$864K | 0.11% | 88 |
|
Other funds holding MRK
ECSS
Chicago Capital's MRK Position: Q2 2026 in Review
Chicago Capital increased its Merck (MRK) stake by 0.2% in Q2 2026, buying an estimated $6.44K and bringing the position to 27,111 shares worth $3.48M. The position accounts for 0.08% of the portfolio, ranked #110.
Chicago Capital first reported a position in MRK in Q1 2018 and has held it in 34 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Chicago Capital held 27,111 shares of Merck worth $3.48M as of Q2 2026.
- Chicago Capital bought 55 Merck shares in Q2 2026, an estimated $6.44K.
- Merck made up 0.08% of Chicago Capital's portfolio in Q2 2026, its #110 holding.
- Chicago Capital first reported a position in Merck in Q1 2018 and has held it in 34 quarters since.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.